Figure 6 — Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy

Research Paper|Volume 12, Issue 4|pp. 3312–3339

Analysis of immune-related signatures of lung adenocarcinoma identified two distinct subtypes: implications for immune checkpoint blockade therapy

Back to articleFigure 6(6 of 6)

100%

Figure 6.Mutational landscape of SMGs in TCGA LUAD cohort stratified by high-/low-risk subtypes. SMGs with significantly different mutation rate were highlighted in bold.